Sam, J., Colombetti, S., Fauti, T., Roller, A., Biehl, M., Fahrni, L., . . . Bacac, M. (2021). Corrigendum: Combination of T-Cell Bispecific Antibodies With PD-L1 Checkpoint Inhibition Elicits Superior Anti-Tumor Activity. Front Oncol.
Chicago Stili AlıntıSam, Johannes, et al. "Corrigendum: Combination of T-Cell Bispecific Antibodies With PD-L1 Checkpoint Inhibition Elicits Superior Anti-Tumor Activity." Front Oncol 2021.
MLA AlıntıSam, Johannes, et al. "Corrigendum: Combination of T-Cell Bispecific Antibodies With PD-L1 Checkpoint Inhibition Elicits Superior Anti-Tumor Activity." Front Oncol 2021.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..